How does bone marrow transplantation affect ovarian function and fertility?

Current Opinion in Obstetrics and Gynecology

Volumn 24, Issue 3, 2012, Pages 164-171

  Jadoul, Pascale ^a   Donnez, Jacques ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

bone marrow transplantation; conditioning regimen; fertility preservation; gonadal damage

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FOLLITROPIN; GONADORELIN AGONIST; MELPHALAN; MUELLERIAN INHIBITING FACTOR;

AGE; BONE MARROW TRANSPLANTATION; CONGENITAL MALFORMATION; CRYOPRESERVATION; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; INCIDENCE; LIVE BIRTH; LOW BIRTH WEIGHT; LOW DRUG DOSE; MYELOABLATIVE CONDITIONING; OVARIAN RESERVE; OVARY FUNCTION; OVARY INSUFFICIENCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURE LABOR; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PUBERTY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTIVE PROCEDURE; REPRODUCTIVE TOXICITY; REVIEW; RISK FACTOR; SURVIVAL RATE; THAWING; UTERUS BLOOD FLOW; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; OVARY; PRIMARY OVARIAN INSUFFICIENCY; TRANSPLANTATION CONDITIONING;

EID: 84861098037     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e328353bb57     Document Type: Review

References (83)

1. Steffens M, Beauloye V, Brichard B, Robert A, et al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf) 2008;69:819-827.
2. Duell T, Vanlint MT, Ljungman P, et al. Health and functional status of longterm survivors of bone marrow transplantation. Ann Intern Med 1997;126:184-192.
3. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-3052.
4. Chatterjee R, Goldstone AH. Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant 1996;17:5-11.
5. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukaemia during childhood. J Pediatr 1997;130:210-216.
6. Teinturier C, Hartmann O, Valteau-Couanet D, et al. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22:989-994;24.
7. Thibaud E, Rodriguez-Macias K, Trivin C, et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998;21:287-290.
8. Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999;80:452-454.
9. Bakker B, Massa GG, Oostdijk W, et al. Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000;159:31-37.
10. Grigg AP, McLachlan R, Zaja J, Szer J. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transplant 2000;26:1089-1095.
11. Couto-Silva AC, Trivin C, Thibaud E, et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28:67-75.
12. Borgmann-Staudt A, Rendtorff R, Reinmuth S, et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant 2012;47:271-276.
13. Jadoul P, Anckaert E, Dewandeleer A, et al. Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. Fertil Steril 2011;96:126-133. This is the first article analyzing ovarian toxicity of BMT by AMH levels showing a much worse outcome by AMH evaluation than by clinical evaluation and FSH levels.
14. Laporte S, Couto-Silva AC, Trabado S, et al. Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr 2011;11:20.
15. Jackson GH, Wood A, Taylor PR, et al. Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK. Leuk Lymphoma 1997;28:127-132.
16. Salooja N, Szydlo RM, Socie G, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001;358:271-276.
17. Carter A, Robison LL, Francisco L, et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 2006;37:1023-1029.
18. Nabhan SK, Bitencourt MA, Duval M, et al. Aplastic Anaemia Working Party, EBMT. Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients. Haematologica 2010;95:1783-1787.
19. Loren AW, Chow E, Jacobsohn DA, et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 2011;17:157-166.
20. Bath LE, Wallace WH, Shaw MP, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18:2368-2374.
21. Anderson RA, Themmen AP, Al-Qahtani A, et al. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006;21:2583-2592.
22. Lutchman Singh K, Muttukrishna S, Stein RC, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 2007;96:1808-1816.
23. Van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Müllerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007;92:3869-3874.
24. Loverro G, Guarini A, Di Naro E, et al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 2007;12:141-147.
25. Lie Fong S, Lugtenburg PJ, Schipper I, et al. Anti-Müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008;23:674-678.
26. Williams D, Crofton PM, Levitt G. Does ifosfamide affect gonadal function? Pediatr Blood Cancer 2008;50:347-351.
27. Rosendahl M, Andersen CY, Ernst E, et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod 2008;23:2475-2483.
28. Fraisse T, Ibecheole V, Streuli I, et al. Undetectable serum anti-Müllerian hormone levels and occurrence of ongoing pregnancy. Fertil Steril 2008;89:723.
29. Spinelli S, Chiodi S, Bacigalupo A, et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. Bone Marrow Transplant 1994;14:373-380.
30. Sklar CA, Kim TH, Williamson JF, Ramsay NK. Ovarian function after successful bone marrow transplantation in postmenarcheal females. Med Pediatr Oncol 1983;11:361-364.
31. Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. QJM 1991;78:265-274.
32. Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. Semin Hematol 1991;28:244-249.
33. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005;62:738-744.
34. Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;5:e8772.
35. Kristensen SG, Rasmussen A, Byskov AG, Andersen CY. Isolation of preantral follicles from human ovarian medulla tissue. Hum Reprod 2011;26:157-166.
36. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;53:727-739. This is an important article on the mechanisms of ovarian toxicity of chemotherapy.
37. Lopez-Ibor B, Schwartz AD. Gonadal failure following busulfan therapy in an adolescent girl. Am J Pediatr Hematol Oncol 1986;8:85-87.
38. Giorgiani G, Bozzola M, Cisternino M, et al. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation. Bone Marrow Transplant 1991;8(Suppl. 1):53.
39. De Sanctis V, Galimberti M, Lucarelli G, et al. Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 1991;66:517-520.
40. Michel G, Socié G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total body irradiation. A report from the SociétéFrançaise de greffe de moelle. J Clin Oncol 1997;15:2238-2246.
41. Sanders JE, Buckner CD, Amos D, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988;6:813-818.
42. Cohen A, Van-Lint MT, Lavagetto A, et al. Pubertal development and fertility in children after bone marrow transplantation. Bone Marrow Transplant 1991;8(Suppl 1):16-20.
43. Singhal S, Powles R, Treleaven J, Horton et al. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant 1996;18:1049-1055.
44. Critchley HO, Wallace W H B, Shalet SM, et al. Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol 1992;99:392-394.
45. Wallace W H B, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003;18:117-121.
46. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Br J Obstet Gynaecol 2002;109:107-114.
47. Satwani P, Morris E, Bradley MB, et al. Reduced intensity and nonmyeloablative allogeneic stem cell transplantation in children and adolescents with malignant and nonmalignant diseases. Pediatr Blood Cancer 2008;50:1-8.
48. Shimizu M, Sawada A, Yamada K, et al. Encouraging results of preserving ovarian function after allo-HSCT with RIC. Bone Marrow Transplant 2012;47:141-142.
49. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 2008;14:543-552.
50. Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 2009;18:311-319.
51. Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 2010;122:803-811.
52. Kim SS, Lee JR, Jee BC, et al. Use of hormonal protection for chemotherapyinduced gonadotoxicity. Clin Obstet Gynecol 2010;53:740-752.
53. Bedaiwy MA, Abou-Setta AM, Desai N, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril 2011;95:906-914.
54. Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009;91:694-697.
55. Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat 2009;117:561-567.
56. Behringer K, Wildt L, Mueller H, et al. German Hodgkin Study Group. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol 2010;21:2052-2060. This is an important article on the absence of protective effect of GnRH agonists in case of highly gonadotoxic chemotherapy.
57. Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin ObstetGynaecol 2010;24:101-112. This is a well written review on results of embryo and oocyte cryopreservation in cancer patients.
58. Cobo A, Domingo J, Pérez S, et al. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 2008;10:268-273.
59. Meirow D, Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. J Natl Cancer Inst Monogr 2005;34:21-25.
60. Moria A, Das M, Shehata F, et al. Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. Fertil Steril 2011;95:1621-1623.
61. Maman E, Meirow D, Brengauz M, et al. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril 2011;95:64-67.
62. Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes. Reprod Biomed Online 2004;8:148-166.
63. Donnez J, Martinez-Madrid B, Jadoul P, et al. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 2006;12:519-535.
64. Donnez J, Jadoul P, Squifflet J, et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract Res Clin Obstet Gynaecol 2010;24:87-100.
65. Jadoul P, Dolmans MM, Donnez J. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? Hum Reprod Update 2010;16:617-630. This is an article showing the safety of ovarian cortex cryopreservation in young girls.
66. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410.
67. Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011;43:437-450. This is a review of pregnancies after ovarian cortex cryopreservation and transplantation validating the technique.
68. Revel A, Laufer N, Ben Meir A, et al. Micro-organ ovarian transplantation enables pregnancy: a case report. Hum Reprod 2011;26:1097-1103.
69. Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 2012;97:387-390.
70. Dolmans MM, Marinescu C, Saussoy P, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010;116:2908-2914. This is an important article showing the limits of ovarian cortex cryopreservation.
71. Meirow D, Hardan I, Dor J, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008;23:1007-1013.
72. Hovatta O. Cryopreservation and culture of human ovarian cortical tissue containing early follicles. Eur J Obstet Gynecol Reprod Biol 2004;113(Suppl 1): S50-S54.
73. Picton HM, Harris SE, Muruvi W, Chambers EL. The in vitro growth and maturation of follicles. Reproduction 2008;136:703-715.
74. Dolmans MM, Martinez-Madrid B, Gadisseux E, et al. Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice. Reproduction 2007;134:253-262.
75. Telfer EE, McLaughlin M, Ding C, Thong KJ. A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod 2008;23:1151-1158.
76. Xu M, Barrett SL, West-Farrell E, et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod 2009;24:2531-2540.
77. Amorim CA, Van Langendonckt A, David A, et al. Survival of human preantral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix. Hum Reprod 2009;24:92-99.
78. Desai N, Alex A, Abdel Hafez F, et al. Three-dimensional in vitro follicle growth: overview of culture models, biomaterials, design parameters and future directions. Reprod Biol Endocrinol 2010;8:119.
79. Silber SJ, Lenahan KM, Levine DJ, et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N Engl J Med 2005;353:58-63.
80. Silber SJ, Gosden RG. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure. N Engl J Med 2007;356:1382-1384.
81. Donnez J, Dolmans MM, Pirard C, et al. Allograft of ovarian cortex between two genetically nonidentical sisters: case report. Hum Reprod 2007;22:2653-2659.
82. Donnez J, Squifflet J, Pirard C, et al. Restoration of ovarian function after allografting of ovarian cortex between genetically nonidentical sisters. Hum Reprod 2010;25:2489-2495.
83. Donnez J, Squifflet J, Pirard C, et al. Live birth after allografting of ovarian cortex between genetically nonidentical sisters. Hum Reprod 2011;26:1384-1388. This is a case report describing a new technique to restore fertility after BMT.